Weill analysis finds high prevalence of hepatitis C

A new Weill Cornell Medicine analysis finds a much higher prevalence of hepatitis C than was previously estimated because some marginalized populations have been excluded from previous data.

New book examines consciousness in brain injury patients

In a new book, a Weill Cornell Medicine physician argues for advocacy and awareness on behalf of people with severe brain injuries who risk becoming deeply marginalized.

Cornell staff advise NYC urban farmers at symposium

Cornell scientists participated in Grow: Urban Garden Symposium in New York City Oct. 14, advising new and experienced gardeners on techniques and procedure to grow produce in the city.

Entrepreneurship Summit NYC set for Nov. 6

The fourth Cornell Entrepreneurship Summit NYC on Nov. 6 will feature will feature 11 entrepreneurial business leaders speaking in 15-minute TED-style talks about their entrepreneurial journeys.

Birth control procedure carries heightened risk

Weill Cornell Medicine investigators found that women who choose to be sterilized using surgical permanent birth control versus getting their tubes tied have a 10-fold risk of follow-up surgery.

Privacy concerns decline about digital health records

Results of a new longitudinal study, published Oct. 5 in the American Journal of Managed Care by Weill Cornell Medical College finds people are increasingly confident about electronic health records.

New 'Weill Cornell Medicine' name announced

After two decades of growth that has transformed Weill Cornell Medical College into a global health care leader, the institution announced today a new name - Weill Cornell Medicine - that captures the full scope of its mission.

Summer interns enhance life in New York communities

From Buffalo to Long Island, the North Country to the Southern Tier, Cornell undergraduates – serving as interns – spent their summer enhancing life in New York.

Cornell dots research collaboration leads to $10M cancer center

Cornell University, in partnership with Memorial Sloan Kettering Cancer Center, is opening a new $10 million MSKCC-Cornell Center for Translation of Cancer Nanomedicines. The center is based on development of nanoparticles called C dots.